Question for you Doc.... If the technology is proven for one of the "cides", wouldn't that mean there's a 99% chance the technology works for most if not all of the "cides"? I'm wondering if we get one or two pharma deals, or when FDA approval is reached for one, then wouldn't the market start pricing in success for the others? What's your opinion?
Market Data 
Markets 
AI
